NORDEA INVESTMENT MANAGEMENT AB
Position in NBIX — Neurocrine Biosciences Inc
CIK 1218210
STOCKHOLM, V7
Position in NBIX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$53,774,032
+$48,091,297 QoQ
Shares Held
319,058
+639.7% QoQ
Ownership
0.314%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#57
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $598,092,248 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
6,592,578 | $473,742,654 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
319,058 | $53,774,032 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
828,628 | $39,169,244 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
14,205 | $7,696,695 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
107,157 | $6,852,689 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
40,566 | $4,500,391 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
127,253 | $4,311,331 | |
| 8 | VTRS |
Viatris Inc
|
229,036 | $3,637,091 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,774,032 | 319,058 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $5,682,735 | 43,136 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,858,059 | 27,202 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $2,106,682 | 15,007 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $1,109,088 | 8,824 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $843,656 | 7,628 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,037,127 | 7,598 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $875,441 | 7,598 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,846,775 | 27,942 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,680,119 | 26,683 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,524,316 | 26,748 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,216,487 | 28,591 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $881,987 | 9,353 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $989,121 | 9,772 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,546,270 | 12,946 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,130,678 | 20,061 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $36,814,199 | 377,659 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $48,797,812 | 520,510 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $47,627,404 | 559,204 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $44,389,929 | 462,829 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $37,243,001 | 382,686 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $18,627,848 | 191,546 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $15,163,661 | 158,202 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $10,526,058 | 109,464 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $23,949,820 | 196,310 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,407,468 | 85,586 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||